A primary technical objective of the **Organ Preservation Market** is to mitigate Ischemia-Reperfusion Injury (IRI), the complex cascade of cellular damage that occurs in two distinct phases. The first phase, ischemia, involves the damage sustained during the cold storage or transport period due to lack of blood flow, oxygen, and nutrients. The second, and often more devastating, phase occurs...